Company intelligence / Profile preview

SewonCellontech

Seoul, South Korea

Ownership: Private
Employees: ~501
Development stage: Other

Overview

Sewon Cellontech commercialized autologous cell therapies (chondrocyte and osteoblast) for cartilage and bone repair, along with several collagen biomaterial products for tissue regeneration and aesthetic applications. Clinical registrations in Korea and internationally, including CE and MFDS approvals, have been obtained for multiple devices and therapeutics[2][4].

Therapeutic areas: OtherDermatologyRheumatology
Modalities: Cell therapyCollagen-based biomaterialMedical deviceBiologic
Industry: Biotech

Partnerships

LinkoCare Life Sciences (Sweden, artificial cornea bio-collagen export)

Beyond the preview

Go deeper on SewonCellontech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SewonCellontech.

Explore the full profile